Brief: Allergy Therapeutics Says Ordinary Shares To Be Suspended From Trading On AIM
Dec 15 (Reuters) - Allergy Therapeutics PLC AGY.L :
* ANNUAL REPORT AND ACCOUNTS DELAYED
* COMPANY'S ORDINARY SHARES WILL BE SUSPENDED FROM TRADING
ON AIM
WITH EFFECT FROM 7.30 A.M. ON 2 JANUARY 2024.
Source text for Eikon: ID:nRSO0237Xa
Further company coverage: AGY.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allergy Therapeutics
See all newsRCS - Allergy Therapeutics - Allergy Therapeutics to present at EAACI 2026
UK's Allergy Therapeutics H1 revenue rises 7%, operating loss widens
Brief: Allergy Therapeutics H1 Pretax Profit GBP -19.33 Million
Allergy Therapeutics - Interim Results for six months ended 31 Dec 2025
Allergy Therapeutics - PDMR Dealings & Shareholding Update